These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13665517)

  • 1. Pharmacology of a new steroid that blocks salt activity of aldosterone and desoxycorticosterone.
    KAGAWA CM; STURTEVANT FM; VAN ARMAN CG
    J Pharmacol Exp Ther; 1959 Jun; 126(2):123-30. PubMed ID: 13665517
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt.
    KAGAWA CM; CELLA JA; VAN ARMAN CG
    Science; 1957 Nov; 126(3281):1015-6. PubMed ID: 13486053
    [No Abstract]   [Full Text] [Related]  

  • 3. Ability of isopregnenolone-21-carboxylates to block renal effects of deoxycorticosterone and aldosterone in rats.
    KAGAWA CM; BROWN EA
    Proc Soc Exp Biol Med; 1960 Dec; 105():648-50. PubMed ID: 13750705
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE MECHANISM OF POTASSIUM-EXCRETORY ACTION OF HYDROCHLOROTHIAZIDE (HCT)].
    SU HT; KOO HY
    Sheng Li Xue Bao; 1964 Mar; 27():26-32. PubMed ID: 14184584
    [No Abstract]   [Full Text] [Related]  

  • 5. STEROIDAL ALDOSTERONE BLOCKERS. VII.
    BROWN EA; BURTNER RR
    J Med Chem; 1963 Nov; 6():732-5. PubMed ID: 14184935
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of the prolonged administration of aldosterone. Antagonistic action of glucocorticoids on the water-salt retention of aldosterone].
    LENZI S; AGNOLI GC; CARIANI A; LODI A; PINELLI G
    Boll Soc Ital Biol Sper; 1962 Mar; 38():241-6. PubMed ID: 14464047
    [No Abstract]   [Full Text] [Related]  

  • 7. Separate effects of aldosterone, DOCA, and methylprednisolone on renal Na-K-ATPase,
    Charney AN; Silva P; Besarab A; Epstein FH
    Am J Physiol; 1974 Aug; 227(2):345-50. PubMed ID: 4277648
    [No Abstract]   [Full Text] [Related]  

  • 8. Water and salt loading in adrenalectomised dogs treated with cortexone, aldosterone, and 9alpha-fluorocortisol.
    DETTBARN WD; GROSS F
    Acta Endocrinol (Copenh); 1956 Aug; 22(4):335-70. PubMed ID: 13354226
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose stimulation of salt retention in patients with aldosterone inhibition.
    GERSING A; BLOOM WL
    Metabolism; 1962 Mar; 11():329-36. PubMed ID: 13898077
    [No Abstract]   [Full Text] [Related]  

  • 10. SODIUM RETENTION FOLLOWING DIURETIC THERAPY.
    RIVERA A; FLORES A; SUAREZ MA; CHAVEZ JM
    Clin Pharmacol Ther; 1964; 5():286-95. PubMed ID: 14168517
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats.
    Huang BS; White RA; Jeng AY; Leenen FH
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R994-R1000. PubMed ID: 19118098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE EFFECT OF A SALT LOAD AND ALDOSTERONE ON THE ACID-BASE-EQUILIBRIUM AND ON THE ELECTROLYTES IN BLOOD AND URINE OF NORMAL SUBJECTS FOLLOWING CHEMICAL BLOCKADE OF THE ADRENAL CORTEX.
    MARTINI O; VOIGT KD; TAMM J; DOELLE W
    Acta Endocrinol (Copenh); 1964 Dec; 47():619-32. PubMed ID: 14253886
    [No Abstract]   [Full Text] [Related]  

  • 13. [RESEARCH ON THE MECHANISM OF THE DIURETIC ACTION OF TRIAMTERENE. I. RELATIONS TO THE PERIPHERAL INHIBITION OF ALDOSTERONE].
    AMBROSOLI S; BARONIO G; FERIOLI V; PENATI MR; PRATI G; SCARPIC L
    Minerva Nefrol; 1964; 11():25-9. PubMed ID: 14160627
    [No Abstract]   [Full Text] [Related]  

  • 14. ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME.
    KOWARSKI A; FINKELSTEIN JW; SPAULDING JS; HOLMAN GH; MIGEON CJ
    J Clin Invest; 1965 Sep; 44(9):1505-13. PubMed ID: 14332163
    [No Abstract]   [Full Text] [Related]  

  • 15. PHARMACOLOGICAL PROPERTIES OF A MINERALOCORTICOID ANTAGONIST (SC-14266).
    KAGAWA CM; BOUSKA DJ; ANDERSON ML; KROL WF
    Arch Int Pharmacodyn Ther; 1964 May; 149():8-24. PubMed ID: 14171763
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of desoxycorticosterone and salt on an experimental nephrotic syndrome due to ligation of a renal vein.
    OMAE T; MASSON GM
    Cleve Clin Q; 1959 Oct; 26():235-9. PubMed ID: 14428845
    [No Abstract]   [Full Text] [Related]  

  • 17. SOME BIOLOGICAL PROPERTIES OF SYNTHETIC 18-HYDROXYTESTOSTERONE.
    KAGAWA CM; PAPPO R
    Endocrinology; 1964 Jun; 74():999-1000. PubMed ID: 14190645
    [No Abstract]   [Full Text] [Related]  

  • 18. Trilostane, FAD286, and the role of aldosterone in the central regulation of blood pressure: focus on "Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats".
    Funder JW
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R992-3. PubMed ID: 19225142
    [No Abstract]   [Full Text] [Related]  

  • 19. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake.
    Sakai RR; McEwen BS; Fluharty SJ; Ma LY
    Kidney Int; 2000 Apr; 57(4):1337-45. PubMed ID: 10760064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and adrenal mechanisms of salt conservation: the excretion of urinary formaldehydogenic steroids and 17-ketosteroids during salt deprivation and desoxycorticosterone administration.
    DAUGHADAY WH; MacBRYDE CM
    J Clin Invest; 1950 May; 29(5):591-601. PubMed ID: 15415463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.